IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting
Findings highlight the limitations of dual-targeting approaches and underscore the need for advanced engineering strategies to improve CAR NK cells beyond antigen targeting and cytokine support in the PDAC microenvironment.